Sign up to save your podcasts
Or
Share Building New Zealand's RNA capabilities
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Building New Zealand's RNA capabilities
Scientists had long been exploring RNA technology as a way to make vaccines before it had it’s breakout appearance during the Covid-19 pandemic.
Since then, interest in the potential uses of RNA to make vaccines and disease treatments has bloomed.
In late 2023 a government-funded platform began work to enhance New Zealand’s capacity to design and make RNA. Three years in, how is the platform going?
Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.
Learn more:
- RNA interference (RNAi) technology is being investigated to help honey bees fight off the varroa mite.
- US based Dyne Therapeutics conducted a clinical trial study of their RNA-based therapeutic for myotonic dystrophy in New Zealand.
- Our Changing World covered how the new RNA vaccine tech works in 2021.
- Dr Lisa Connor spoke to RNZ’s health reporter Ruth Hill last August after the US made funding cuts to their RNA vaccine research.
Guests:
- Dr Lisa Connor, Malaghan Institute of Medical Research
- Dr Rebecca McKenzie, Malaghan Institute of Medical Research
Go to this episode on rnz.co.nz for more details
View all episodes
By RNZ
4.8
2424 ratings
Scientists had long been exploring RNA technology as a way to make vaccines before it had it’s breakout appearance during the Covid-19 pandemic.
Since then, interest in the potential uses of RNA to make vaccines and disease treatments has bloomed.
In late 2023 a government-funded platform began work to enhance New Zealand’s capacity to design and make RNA. Three years in, how is the platform going?
Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.
Learn more:
- RNA interference (RNAi) technology is being investigated to help honey bees fight off the varroa mite.
- US based Dyne Therapeutics conducted a clinical trial study of their RNA-based therapeutic for myotonic dystrophy in New Zealand.
- Our Changing World covered how the new RNA vaccine tech works in 2021.
- Dr Lisa Connor spoke to RNZ’s health reporter Ruth Hill last August after the US made funding cuts to their RNA vaccine research.
Guests:
- Dr Lisa Connor, Malaghan Institute of Medical Research
- Dr Rebecca McKenzie, Malaghan Institute of Medical Research
Go to this episode on rnz.co.nz for more details
More shows like Our Changing World
View all
The Science Show
128 Listeners
BBC Inside Science
414 Listeners
Science Weekly
411 Listeners
Curious Cases
758 Listeners
Saturday Morning
37 Listeners
Nine To Noon
16 Listeners
Sunday Morning
13 Listeners
Mediawatch
12 Listeners
FROM ZERO
1 Listeners
CrowdScience
477 Listeners
Go Ahead Caller
1 Listeners
Gone By Lunchtime
26 Listeners
Here Now
1 Listeners
Slice of Heaven
1 Listeners
The Lost
42 Listeners
Pants on Fire
103 Listeners
The Science Of…
1 Listeners
The Front Page
15 Listeners
The Worst Sitcom Ever Made
7 Listeners
The Detail
47 Listeners
Best of Storytime
3 Listeners
Between Two Beers Podcast
141 Listeners
The Citizen's Handbook
3 Listeners
After the Virus
0 Listeners
The Service
31 Listeners
Short Story Stack
0 Listeners
Fight for the Wild
4 Listeners
What The Duck?!
46 Listeners
Deer Wars
4 Listeners
Voice of Tangaroa
2 Listeners
Hair and Loathing
1 Listeners
Sci Fi / Sci Fact
3 Listeners
The Stolen Children of Aotearoa
3 Listeners
No Stupid Questions with Susan Edmunds
4 Listeners
Search & Rescue NZ
0 Listeners